Remdesivir is an investigational drug being studiedto treat coronavirus infection, also known as COVID-19. It has not beenapproved by the FDA for general use. However, the FDA is now allowingremdesivir to be used in human studies and for emergency use in certainhospitalized patients. More information should be provided by the doctor fromeither the Informed Consent form for a study or the FDA Fact Sheet for Patientsand Parents/Caregivers for emergency use.
Remdesiviris given by injection into a vein usually once daily for 5 to 10 days. It isinfused over a period ranging from 30 minutes to 2 hours.